BYSI Long Call Strategy

BYSI (BeyondSpring Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

BYSI (BeyondSpring Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $59.6M, a beta of 0.41 versus the broader market, a 52-week range of 1.21-3.44, average daily share volume of 17K, a public-listing history dating back to 2017, approximately 40 full-time employees. These structural characteristics shape how BYSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.41 indicates BYSI has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on BYSI?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current BYSI snapshot

As of May 15, 2026, spot at $1.38, ATM IV 20.40%, IV rank 0.00%, expected move 5.85%. The long call on BYSI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on BYSI specifically: BYSI IV at 20.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a BYSI long call, with a market-implied 1-standard-deviation move of approximately 5.85% (roughly $0.08 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BYSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on BYSI should anchor to the underlying notional of $1.38 per share and to the trader's directional view on BYSI stock.

BYSI long call setup

The BYSI long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BYSI near $1.38, the first option leg uses a $1.38 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BYSI chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BYSI shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$1.38N/A

BYSI long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

BYSI long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on BYSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on BYSI

Long calls on BYSI express a bullish thesis with defined risk; traders use them ahead of BYSI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

BYSI thesis for this long call

The market-implied 1-standard-deviation range for BYSI extends from approximately $1.30 on the downside to $1.46 on the upside. A BYSI long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current BYSI IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BYSI at 20.40%. As a Healthcare name, BYSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BYSI-specific events.

BYSI long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BYSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BYSI alongside the broader basket even when BYSI-specific fundamentals are unchanged. Long-premium structures like a long call on BYSI are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BYSI chain quotes before placing a trade.

Frequently asked questions

What is a long call on BYSI?
A long call on BYSI is the long call strategy applied to BYSI (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With BYSI stock trading near $1.38, the strikes shown on this page are snapped to the nearest listed BYSI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BYSI long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the BYSI long call priced from the end-of-day chain at a 30-day expiry (ATM IV 20.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BYSI long call?
The breakeven for the BYSI long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BYSI market-implied 1-standard-deviation expected move is approximately 5.85%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on BYSI?
Long calls on BYSI express a bullish thesis with defined risk; traders use them ahead of BYSI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current BYSI implied volatility affect this long call?
BYSI ATM IV is at 20.40% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related BYSI analysis